EUVIMEDEUVIMED entdecken
Crossref

Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity

Xindi Qian, Wenzhe Yi, Wenlu Yan, Ying Cai, Shuangshuang Hu, Dan Yan, Zhiwen Zhao, Rongzhang Li, Liying Wang, Huixiong Xu, Yaping Li iD

Advanced Materials · 2025-03 · 37 (12)

DOI: 10.1002/adma.202413289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 16.02.2025. Verfasst von Xindi Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound and Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Educ…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Antigen-Presenting Cells, T-Lymphocytes, Immunotherapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ultrasound therapy has turned up as a noninvasive multifunctional tool for cancer immunotherapy. However, the insufficient co‐stimulating molecules and loss of peptide‐major histocompatibility complex I (MHC‐I) expression on tumor cells lead to poor therapy of sonoimmunotherapies. Herein, this work develops a sonosensitive system to augment MHC‐I unrestricted natural killer (NK) cell‐mediated innate immunity and T cell‐mediated adaptive immunity by leveraging antigen presentation cell (APC)‐like tumor cells. Genetically engineered tumor cells featuring sufficient co‐stimulating molecules are cryo‐shocked and conjugated with a sonosensitizer, hematoporphyrin monomethyl ether, using click chemistry. These cells (DPNLs) exhibit characteristics of tumor and draining lymph node homing. Under ultrasound, NK cell‐mediated innate immunity within the tumor microenvironment could be activated, and T cells in the tumor‐draining lymph nodes (TDLNs) are stimulated through co‐stimulatory molecules. In combination with programmed cell death ligand 1 (PD‐L1) antibody, DPNLs extend the survival time and inhibited lung metastasis in triple‐negative breast cancer (TNBC) models. This study provides an alternative approach for sonoimmunotherapy with precise sonosensitizer delivery and enhanced NK cell and T cell activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalAntigen-Presenting CellsT-LymphocytesImmunotherapyUltrasonic TherapyAnimalsMiceCell Line, TumorHumansFemaleHematoporphyrins

Stichwörter der Autor:innen

adaptive immunityantigen presentationinnate immunitysonoimmunotherapytumor cell reprogramming

Substanzen

Hematoporphyrins

Autor:innen und Institutionen

  • Department of Medical Ultrasound and Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, School of Medicine, Tongji University, Shanghai, 2000…
  • State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Department of Ultrasound, Zhongshan Hospital, Institute of Ultrasound in Medicine and Engineering, Fudan University, Shanghai, 200032, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Yantai Key Laboratory of Nanomedicine & Advanced Preparations Yantai Institute of Materia Medica Shandong, Shanghai, 264000, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264000, China.

ORCID-Profile: Yaping Li

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shanghai Sailing Program
  • National Basic Research Program of China

Zitieren

APA

Qian, X., Yi, W., Yan, W., Cai, Y., Hu, S., Yan, D., Zhao, Z., Li, R., Wang, L., Xu, H., & Li, Y. (2025). Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity. Advanced Materials, 37(12). https://doi.org/10.1002/adma.202413289

Vancouver

Qian X, Yi W, Yan W, Cai Y, Hu S, Yan D, et al. Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity. Advanced Materials. 2025;37(12). doi:10.1002/adma.202413289

BibTeX
@article{Qian2025,
  author = {Qian, Xindi and Yi, Wenzhe and Yan, Wenlu and Cai, Ying and Hu, Shuangshuang and Yan, Dan and Zhao, Zhiwen and Li, Rongzhang and Wang, Liying and Xu, Huixiong and Li, Yaping},
  title = {Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {12},
  doi = {10.1002/adma.202413289}
}
Kostenlos starten →